A detailed history of Cornerstone Planning Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 26 shares of EXAS stock, worth $1,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 26 -0.0%
Holding current value
$1,375
Previous $1.45 Million 24.81%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$56.27 - $73.77 $56 - $73
-1 Reduced 3.7%
26 $1.61 Million
Q4 2023

Feb 12, 2024

BUY
$59.06 - $75.72 $1,535 - $1,968
26 Added 2600.0%
27 $2 Million
Q3 2023

Nov 08, 2023

BUY
$65.94 - $99.04 $65 - $99
1 New
1 $68,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.